packageAumolertinib

aumolertinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Aumolertinib is an EGFR tyrosine kinase inhibitor studied for the treatment of non-small-cell lung cancer. It is considered investigational and is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q105317437 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:aumolertinib
ATC codes:L01EB11
DrugBank:DB16640
PubChem CID:121280087
Wikidata:Q105317437
formula:C30H35N7O2
molar mass:525.657 g/mol (PubChem CID 121280087)
logP:4.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown